{
  "context": {
    "rules": [
      "Rule1: The drug is contaminated, or, whenever the regulator has approved the drug and the drug has a completed test at the facility, under the condition that it is not the case that the facility passes the inspection or meets the standards, the facility is shutdown.",
      "Rule2: If the equipment has detected contamination in the drug, then the drug is not contaminated.",
      "Rule3: In the case that the operator has reported a defect in the drug, the drug is not contaminated.",
      "Rule4: If the equipment is under scheduled maintenance, then provided that it is not the case that if the equipment is malfunctioning then the equipment is not operating, the equipment is under emergency maintenance.",
      "Rule5: In the event that the facility is compliant with the regulation, the facility is approved for the drug.",
      "Rule6: Under the condition that the drug is a critical supply, if the equipment is not under scheduled maintenance, then the production of the drug is not delayed.",
      "Rule7: If an urgent meeting is scheduled between the manufacturer and the regulator, then either a meeting is scheduled between the manufacturer and the regulator or, provided that it is not the case that if the regulator has an audit finding for the facility and if it is not the case that the facility passes the inspection or meets the standards then the facility is shutdown, the facility has not taken corrective action for the regulator.",
      "Rule8: Whenever the regulator has conducted a preliminary review of the drug, then if the drug has a completed test at the facility, under the condition that it is not the case that the facility passes the inspection or meets the standards, the facility is shutdown.",
      "Rule9: Either the regulator has conducted a preliminary review of the drug or the regulator has conducted a final review of the drug.",
      "Rule10: If test1 and test2 have contradictory results, then test1 is validated.",
      "Rule11: Either test1 and test2 have contradictory results, or, under the condition that the regulator has conducted a final review of the drug and the drug has a completed test at the facility and it is not the case that the facility passes the inspection or meets the standards, the facility is shutdown.",
      "Rule12: In the case that the facility is certified for the equipment, the drug is profitable.",
      "Rule13: Whenever analysis1 and analysis2 have conflicting data, analysis1 is reliable.",
      "Rule14: If analysis1 and analysis2 have conflicting data, then it is not the case that analysis1 is reliable.",
      "Rule15: Either analysis1 and analysis2 have conflicting data, or, provided that it is not the case that if test1 and test2 have contradictory results then it is not the case that test1 is validated, the regulator has not opened an investigation into test1.",
      "Rule16: If the facility passes the inspection, then the facility is compliant with the regulation.",
      "Rule17: Under the condition that the facility meets the standards, the facility is certified for the equipment.",
      "Rule18: Whenever the drug has an ordered test at the facility, then if it is not the case that the facility passes the inspection or meets the standards, the facility is shutdown.",
      "Rule19: Either the drug has an ordered test at the facility or the drug has a completed test at the facility.",
      "Rule20: If the regulator has reviewed data for the drug, then whenever the drug has a completed test at the facility and it is not the case that the facility passes the inspection or meets the standards, the facility is shutdown.",
      "Rule21: Either the regulator has reviewed data for the drug or the regulator has approved the drug.",
      "Rule22: In the case that it is not the case that if the regulator has approved the drug and the drug has a completed test at the facility and it is not the case that the facility passes the inspection or meets the standards then the facility is shutdown, the manufacturer has appealed the decision with the regulator.",
      "Rule23: Should it not be the case that whenever the regulator has approved the drug and the drug has a completed test at the facility and it is not the case that the facility passes the inspection or meets the standards then the facility is shutdown, then the manufacturer has not appealed the decision with the regulator.",
      "Rule24: Under the condition that it is not the case that the equipment has detected contamination in the drug or the operator has reported a defect in the drug, the equipment is operating.",
      "Rule25: If it is not the case that the equipment has detected contamination in the drug or the operator has reported a defect in the drug, then the equipment is malfunctioning.",
      "Rule26: Whenever it is not the case that if the regulator has an audit finding for the facility and if it is not the case that the facility passes the inspection or meets the standards then the facility is shutdown, the facility has taken corrective action for the regulator.",
      "Rule27: If it is not the case that whenever test1 and test2 have contradictory results then it is not the case that test1 is validated, the regulator has opened an investigation into test1.",
      "Rule28: Under the condition that it is not the case that the facility passes the inspection or meets the standards, the facility is not shutdown.",
      "Rule29: If the equipment is not under scheduled maintenance, then the production of the drug is delayed."
    ],
    "facts": [
      "Fact1: The drug is a critical supply.",
      "Fact2: The regulator has an audit finding for the facility.",
      "Fact3: An urgent meeting is scheduled between the manufacturer and the regulator.",
      "Fact4: It is not the case that the facility is approved for the drug.",
      "Fact5: The equipment is not under emergency maintenance.",
      "Fact6: A meeting is not scheduled between the manufacturer and the regulator."
    ]
  },
  "question": "The drug is profitable."
}